A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection

IFNM, Institut Farmaseutikal & Nutraseutikal Malaysia (2017) A Study on the Potential of Active Constituent from Senna spectabilis in Treating Leishmania major Infection. IPHARM Newsletter, 1 (1).

[img] PDF - Published Version
Available under License Creative Commons Attribution.

Download (697Kb)

    Abstract

    Leishmaniasis affects millions of people each year. It consists of a group of tropical infections that are effecting human populations in mainly low-income countries. Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis (CL) are the main forms of Leishmaniasis which cause mortality, chronic disability and poverty. Leishmanasis is among three of most neglected diseases in the world, together with Human African Trypanosomiasis (HAT) and Chagas’ disease. These diseases are termed as neglected diseases because they are receiving very limited press attention as well as research funding as compared to HIV/AIDS, tuberculosis and malaria. In 2003, Drugs for Neglected Diseases Initiative (DNDi) which is a non-profit drug R&D agency focusing on developing new treatments for neglected diseases was established

    Item Type: Article
    Subjects: R Medicine > RM Therapeutics. Pharmacology
    R Medicine > RS Pharmacy and materia medica
    Divisions: 6. Institut Farmaseutikal & Nutraseutikal Malaysia (Malaysian Institute of Pharmaceuticals & Nutraceuticals > IPHARM Newsletter
    Depositing User: Administrator Automasi
    Date Deposited: 11 Sep 2017 17:59
    Last Modified: 11 Sep 2017 17:59
    URI: http://eprints.usm.my/id/eprint/36440

    Actions (login required)

    View Item
    Share